Kush Parmar - 15 May 2024 Form 4 Insider Report for Rallybio Corp (RLYB)

Reporting relationship: Director
Issuer ticker: RLYB
Reported as of: 15 May 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 17 May 2024, 17:05:09 UTC
Prior SEC filing: 04 Jan 2024
Next SEC filing: 14 Jun 2024
Source filing: View source filing
Reporting owner signature: By: /s/ Michael Greco, Attorney-in-Fact

Key filing fact

Kush Parmar filed Form 4 for Rallybio Corp (RLYB) on 17 May 2024.

Key facts

This page summarizes Kush Parmar's Form 4 filing for Rallybio Corp (RLYB).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 17 May 2024, 17:05.

Change

Previous filing in this sequence was filed on 04 Jan 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RLYB transaction Derivative

Option (Right to Buy)

Award

Transaction value: $0
Shares: +16,500
Change %
Price: $0.000000
Shares after: 16,500
Date: 15 May 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 16,500
Exercise price: $1.91
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option was granted under the Company's 2021 Equity Incentive Plan. The option vests on the earlier of May 15, 2025 or the date of the Company's 2025 Annual Meeting of Stockholders.